Enrollment in AZURE-1, a global pivotal clinical trial evaluating the efficacy and safety of brelovitug compared to delayed treatment, continues on track REDWOOD CITY, Calif., Sept. 04, 2025 (GLOBE ...
Microsoft Azure customers worldwide now gain access to Ryght's intelligent platform to take advantage of the scalability, reliability, and agility of Azure to drive application development and shape ...
AZURE-2 evaluates the efficacy and safety of brelovitug as a monotherapy compared head-to-head with Hepcludex (bulevirtide) Enrollment in AZURE-1,a global pivotal clinical trial evaluating the ...
The unified storefront provides a platform for customers to try out and buy solutions, bridging the gap where AI adoption ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback